Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness and Implementation Outcomes of a Multicomponent Intervention for Aromatase Inhibitor-Associated Musculoskeletal Symptoms: A Hybrid Type 1 Randomized Controlled Trial

NCT07409948 is registered in ClinicalTrials.gov with Addis Ababa University as lead sponsor.

NCT NCT07409948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07409948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness and Implementation Outcomes of a Multicomponent Intervention for Aromatase Inhibitor-Associated Musculoskeletal Symptoms: A Hybrid Type 1 Randomized Controlled Trial
Lead sponsor
Addis Ababa University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
November 30, 2026
Enrollment
88 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arthralgia, breast neoplasms, fatigue syndrome, chronic, musculoskeletal diseases, musculoskeletal pain, pain